Form 8-K - Current report:
SEC Accession No. 0001213900-25-004256
Filing Date
2025-01-16
Accepted
2025-01-16 17:00:10
Documents
14
Period of Report
2025-01-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0227841-8k_ispecimen.htm   iXBRL 8-K 23704
2 PRESS RELEASE DATED JANUARY 16, 2025 ea022784102ex99-1_ispecimen.htm EX-99.1 7796
  Complete submission text file 0001213900-25-004256.txt   207815

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ispc-20250116.xsd EX-101.SCH 3018
4 XBRL LABEL FILE ispc-20250116_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE ispc-20250116_pre.xml EX-101.PRE 22361
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0227841-8k_ispecimen_htm.xml XML 3672
Mailing Address 8 CABOT ROAD SUITE 1800 WOBURN MA 08101
Business Address 8 CABOT ROAD SUITE 1800 WOBURN MA 08101 781-301-6700
iSpecimen Inc. (Filer) CIK: 0001558569 (see all company filings)

EIN.: 270480143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40501 | Film No.: 25536257
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)